Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
RHEUMATOLOGY, cilt.60, sa.5, ss.2327-2332, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 60 Sayı: 5
- Basım Tarihi: 2021
- Doi Numarası: 10.1093/rheumatology/keaa596
- Dergi Adı: RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
- Sayfa Sayıları: ss.2327-2332
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
Objectives. Anakinra is proven to be effective in controlled trials in terms of attack frequency and subclinical inflammation in colchicine-resistant patients. The objective of this study was to review the patients followed in our single centre with FMF who received anakinra because of insufficient colchicine response.